Related Experiment Video
Updated: Jun 13, 2026

High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli
Published on: July 30, 2014
Human SUMO fusion systems enhance protein expression and solubility
Zhongyuan Wang1, Haolong Li, Wei Guan
1Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, Jilin University, 2519 Jiefang Road, Changchun 130021, China.
Human SUMO1 and SUMO2 enhance the expression and solubility of difficult-to-express proteins in E. coli. These small ubiquitin-related modifier (SUMO) fusion tags improve protein production and facilitate purification, offering a valuable tool for biotechnology.
Area of Science:
- Biotechnology
- Molecular Biology
- Protein Engineering
Background:
- Recombinant protein production in E. coli often faces challenges with low yields of soluble, functional proteins.
- Yeast SUMO (small ubiquitin-related modifier) has previously shown promise in enhancing heterologous protein expression.
- The efficacy of human SUMOs in improving protein expression remains largely unexplored.
Purpose of the Study:
- To investigate the potential of human SUMO1 and SUMO2 as fusion tags for enhancing the expression and solubility of difficult-to-express proteins.
- To compare the effectiveness of SUMO1 and SUMO2 tags, individually and in combination with ubiquitin, for protein production in E. coli.
- To establish a purification strategy for recombinant proteins produced using SUMO fusion technology.
Main Methods:
- Construction of human SUMO1 and SUMO2 fusion expression vectors.
- Fusion of model proteins (MMP13 and eGFP) to SUMO1 and SUMO2 tags.
- Expression of fusion constructs in E. coli and assessment of protein expression and solubility.
- Evaluation of SUMO2-ubiquitin and ubiquitin-SUMO2 fusion systems.
- Purification of recombinant eGFP using deubiquitinase cleavage and Ni-Sepharose chromatography.
Main Results:
- Both human SUMO1 and SUMO2 significantly enhanced the solubility of MMP13 and eGFP.
- SUMO2 demonstrated a more pronounced positive effect on protein solubility compared to SUMO1.
- SUMO2-ubiquitin and ubiquitin-SUMO2 fusions improved eGFP expression and solubility, outperforming ubiquitin alone.
- The sequential arrangement of SUMO2 and ubiquitin did not significantly impact expression or solubility outcomes.
- High-purity eGFP was successfully purified from the SUMO2-ubiquitin-eGFP fusion construct.
Conclusions:
- Human SUMO1 and SUMO2 serve as effective gene fusion technologies for boosting heterologous protein expression and solubility in E. coli.
- SUMO2 exhibits superior performance in enhancing protein solubility.
- SUMO-ubiquitin fusion systems offer a viable alternative for improving protein production and purification.
- This technology provides a valuable strategy for overcoming challenges in recombinant protein manufacturing.
Related Concept Videos
Tagging and Fusion Proteins
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...

